Description:
Assess the value of PET/CT in the diagnosis, staging, response evaluation, and relapse monitoring of lung cancer.
Sponsor:
Government Study Link:
ClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468